229 related articles for article (PubMed ID: 35546306)
1. A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.
Crow AJD; Janssen JM; Marshall C; Moffit A; Brennan L; Kohler CG; Roalf DR; Moberg PJ
Am J Med Genet A; 2022 Aug; 188(8):2277-2292. PubMed ID: 35546306
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
3. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
Lorenzo J; Barton B; Arnold SS; North KN
J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
[TBL] [Abstract][Full Text] [Related]
4. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
5. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
[TBL] [Abstract][Full Text] [Related]
6. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
[TBL] [Abstract][Full Text] [Related]
7. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
Eby NS; Griffith JL; Gutmann DH; Morris SM
Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
[TBL] [Abstract][Full Text] [Related]
8. The impact of ADHD on the cognitive and academic functioning of children with NF1.
Pride NA; Payne JM; North KN
Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
[TBL] [Abstract][Full Text] [Related]
9. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
[TBL] [Abstract][Full Text] [Related]
10. Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1.
Vaucheret Paz E; López Ballent A; Puga C; García Basalo MJ; Baliarda F; Ekonen C; Ilari R; Agosta G
Neurologia (Engl Ed); 2019; 34(6):353-359. PubMed ID: 28431841
[TBL] [Abstract][Full Text] [Related]
11. Social functioning in adults with neurofibromatosis type 1.
Pride NA; Crawford H; Payne JM; North KN
Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
[TBL] [Abstract][Full Text] [Related]
12. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
van der Vaart T; Rietman AB; Plasschaert E; Legius E; Elgersma Y; Moll HA;
Neurology; 2016 Jan; 86(2):154-60. PubMed ID: 26519538
[TBL] [Abstract][Full Text] [Related]
14. Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.
Loitfelder M; Huijbregts SC; Veer IM; Swaab HS; Van Buchem MA; Schmidt R; Rombouts SA
Brain Connect; 2015 Jun; 5(5):312-20. PubMed ID: 25705926
[TBL] [Abstract][Full Text] [Related]
15. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
[TBL] [Abstract][Full Text] [Related]
16. Cognitive control in adolescents with neurofibromatosis type 1.
Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
[TBL] [Abstract][Full Text] [Related]
17. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
Lidzba K; Granström S; Lindenau J; Mautner VF
Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
[TBL] [Abstract][Full Text] [Related]
18. Preliteracy impairments in children with neurofibromatosis type 1.
Arnold SS; Payne JM; Lorenzo J; North KN; Barton B
Dev Med Child Neurol; 2018 Jul; 60(7):703-710. PubMed ID: 29667706
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in neurofibromatosis type 1.
Ozonoff S
Am J Med Genet; 1999 Mar; 89(1):45-52. PubMed ID: 10469436
[TBL] [Abstract][Full Text] [Related]
20. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
